FFT Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-50
Closed -$5K 105
2021
Q2
$5K Buy
+50
New +$4.25K ﹤0.01% 239

Other funds holding ARKG

FFT Wealth Management's ARKG Position: Q3 2021 in Review

FFT Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2021, closing a stake of 50 shares — an estimated $5K sold.

FFT Wealth Management first reported a position in ARKG in Q2 2021 and held it in 1 quarter. The position peaked at $5K in Q2 2021. 468 funds tracked by Wall St. Rank hold ARKG as of Q3 2021.

  • FFT Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q3 2021 after selling out during the quarter.
  • FFT Wealth Management sold 50 ARK Genomic Revolution ETF shares in Q3 2021, an estimated $5K.
  • FFT Wealth Management first reported a position in ARK Genomic Revolution ETF in Q2 2021 and held it in 1 quarter.
  • FFT Wealth Management's ARK Genomic Revolution ETF position peaked at $5K in Q2 2021.
  • 468 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2021.

Based on FFT Wealth Management's 13F filing for Q3 2021, filed 12 Nov 2021.